NO20053959L - Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler - Google Patents
Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddelerInfo
- Publication number
- NO20053959L NO20053959L NO20053959A NO20053959A NO20053959L NO 20053959 L NO20053959 L NO 20053959L NO 20053959 A NO20053959 A NO 20053959A NO 20053959 A NO20053959 A NO 20053959A NO 20053959 L NO20053959 L NO 20053959L
- Authority
- NO
- Norway
- Prior art keywords
- active ingredients
- combination
- active
- aqonist
- medication
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03004184A EP1452179A1 (en) | 2003-02-27 | 2003-02-27 | Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid |
PCT/EP2004/001960 WO2004075896A1 (en) | 2003-02-27 | 2004-02-27 | Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053959D0 NO20053959D0 (no) | 2005-08-25 |
NO20053959L true NO20053959L (no) | 2005-11-28 |
Family
ID=32748803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053959A NO20053959L (no) | 2003-02-27 | 2005-08-25 | Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler |
Country Status (32)
Country | Link |
---|---|
US (1) | US20070020190A1 (ko) |
EP (3) | EP1452179A1 (ko) |
JP (1) | JP2006519204A (ko) |
KR (1) | KR20050104367A (ko) |
CN (2) | CN100370986C (ko) |
AR (1) | AR043419A1 (ko) |
AT (1) | ATE401887T1 (ko) |
AU (1) | AU2004216472B2 (ko) |
BR (1) | BRPI0408047A (ko) |
CA (1) | CA2517321A1 (ko) |
CY (1) | CY1108360T1 (ko) |
DE (1) | DE602004015260D1 (ko) |
DK (1) | DK1603565T3 (ko) |
EA (1) | EA008828B1 (ko) |
ES (1) | ES2309503T3 (ko) |
HK (1) | HK1087009A1 (ko) |
HR (1) | HRP20050726A2 (ko) |
MA (1) | MA27630A1 (ko) |
ME (1) | MEP32208A (ko) |
MX (1) | MXPA05009007A (ko) |
NO (1) | NO20053959L (ko) |
NZ (1) | NZ541997A (ko) |
PE (1) | PE20050290A1 (ko) |
PL (1) | PL377814A1 (ko) |
PT (1) | PT1603565E (ko) |
RS (1) | RS20050615A (ko) |
SA (1) | SA04250122B1 (ko) |
SI (1) | SI1603565T1 (ko) |
TN (1) | TNSN05186A1 (ko) |
UA (1) | UA82217C2 (ko) |
WO (1) | WO2004075896A1 (ko) |
ZA (1) | ZA200506820B (ko) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
JP2007500676A (ja) * | 2003-07-31 | 2007-01-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤 |
EP1654001A2 (en) * | 2003-08-05 | 2006-05-10 | Boehringer Ingelheim International GmbH | Medicaments for inhalation comprising steroids and a betamimetic |
EP1670482B2 (en) | 2003-09-16 | 2022-06-29 | Covis Pharma B.V. | Use of ciclesonide for the treatment of respiratory diseases |
RU2420285C2 (ru) * | 2005-03-16 | 2011-06-10 | Меда Фарма Гмбх Унд Ко.Кг | Комбинация r,r-гликопирролата и монтелукаста для лечения респираторных заболеваний и фармацевтическая композиция на ее основе |
MX2007012084A (es) * | 2005-03-30 | 2007-11-21 | Schering Corp | Medicamentos y metodos que combinan un anticolinergico, un corticosteroide y un agonista beta de accion prolongada. |
EA013351B1 (ru) * | 2005-08-01 | 2010-04-30 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Фармацевтические препараты, содержащие бета-агонист длительного действия, для введения путем распыления |
ATE529399T1 (de) | 2005-11-10 | 2011-11-15 | Nicholas S Bodor | Sanfte anticholinerge ester |
DE602006008665D1 (de) * | 2005-12-21 | 2009-10-01 | Meda Pharma Gmbh & Co Kg | Kombination von r,r-glycopyrrolat, rolipram und budesonid zur behandlung von entzündungskrankheiten |
WO2007135024A1 (en) * | 2006-05-24 | 2007-11-29 | Boehringer Ingelheim International Gmbh | New long-acting drug combinations for the treatment of respiratory diseases |
EP1953143A1 (en) * | 2007-01-30 | 2008-08-06 | CHIESI FARMACEUTICI S.p.A. | Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone monohydrochloride |
CL2008000500A1 (es) * | 2007-02-19 | 2008-09-05 | Cipla Ltd | Combinacion farmaceutica que comprende una combinacion de dos o mas broncodilatadores o una combinacion de al menos un broncodilatador y al menos un corticosteroide; uso para tratar o prevenir una enfermedad respiratoria; e inhalador que comprende di |
EP2534957B1 (en) | 2007-12-14 | 2015-05-27 | AeroDesigns, Inc | Delivering aerosolizable products |
EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
EP2309858A4 (en) * | 2008-07-31 | 2011-09-14 | Dekel Pharmaceuticals Ltd | COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES |
WO2010097188A1 (en) * | 2009-02-25 | 2010-09-02 | Chiesi Farmaceutici S.P.A. | Inhalation particles comprising a salt of carmoterol and a corticosteroid |
KR20120023663A (ko) * | 2009-05-25 | 2012-03-13 | 키에시 파르마슈티시 엣스. 피. 에이. | 폐 계면활성제 및 스테로이드를 포함하는 치료적 조합 |
AU2015201037C1 (en) * | 2009-05-29 | 2017-07-27 | Pearl Therapeutics, Inc. | Respiratory delivery of active agents |
LT2435025T (lt) | 2009-05-29 | 2016-09-26 | Pearl Therapeutics, Inc. | Veikliosios medžiagos tiekimas per kvėpavimo takus |
WO2011136753A1 (en) * | 2010-04-26 | 2011-11-03 | Mahmut Bilgic | Combination of carmoterol and fluticasone for use in the treatment respiratory diseases |
CN102247597B (zh) * | 2010-05-19 | 2015-01-07 | 天津金耀集团有限公司 | 一种糖皮质激素与支气管扩张剂的吸入剂 |
AU2011278096B2 (en) * | 2010-07-16 | 2014-08-28 | Cipla Limited | Pharmaceutical compositions comprising R (+) budesonide and one or more bronchodilators |
WO2012010854A1 (en) | 2010-07-23 | 2012-01-26 | Cipla Limited | Inhalation formulations comprising carmoterol in combination with a corticosteroid |
CN102416179B (zh) * | 2010-09-28 | 2014-05-07 | 益得生物科技股份有限公司 | 用于哮喘的吸入性复方组合物 |
TWI399202B (zh) * | 2011-03-17 | 2013-06-21 | Intech Biopharm Ltd | 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法 |
EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
SI2968312T1 (en) * | 2013-03-15 | 2018-06-29 | Verona Pharma PLC Bradley Court | Combination of Medicines |
US10117891B2 (en) | 2014-09-16 | 2018-11-06 | India Globalization Capital, Inc. | Cannabinoid composition for treating pain |
WO2016085933A1 (en) * | 2014-11-24 | 2016-06-02 | The Board Of Trustees Of The University Of Illinois | Method of preventing or treating a pulmonary disease or condition |
US10751300B2 (en) | 2015-01-25 | 2020-08-25 | India Globalization Capital, Inc. | Composition and method for treating seizure disorders |
WO2017027651A1 (en) * | 2015-08-12 | 2017-02-16 | India Globalization Capital, Inc. | Method and composition for treating cachexia and eating disorders |
US11351152B2 (en) | 2016-06-15 | 2022-06-07 | India Globalization Capital, Inc. | Method and composition for treating seizure disorders |
CN115337311B (zh) * | 2022-09-26 | 2023-05-09 | 南京恒道医药科技股份有限公司 | 一种治疗呼吸***疾病的组合物及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5874063A (en) * | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
ATE284677T1 (de) * | 1997-03-20 | 2005-01-15 | Schering Corp | Herstellung von pulveragglomeraten |
IT1303788B1 (it) * | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
US20020081266A1 (en) * | 1999-08-20 | 2002-06-27 | Norton Healthcare Ltd. | Spray dried powders for pulmonary or nasal administration |
PE20011227A1 (es) * | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
DZ3358A1 (fr) * | 2000-05-22 | 2001-11-29 | Chiesi Farma Spa | Formulations en solution pharmaceutiques pour inhalateurs-doseurs sous pression |
JP2005523905A (ja) * | 2002-03-01 | 2005-08-11 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | ホルモテロール(formoterol)超微細調合物 |
EP1340492A1 (en) * | 2002-03-01 | 2003-09-03 | CHIESI FARMACEUTICI S.p.A. | Aerosol formulations for pulmonary administration of medicaments having systemic effects |
EP1595531A1 (en) * | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
-
2003
- 2003-02-27 EP EP03004184A patent/EP1452179A1/en not_active Withdrawn
-
2004
- 2004-02-26 PE PE2004000199A patent/PE20050290A1/es not_active Application Discontinuation
- 2004-02-27 US US10/546,619 patent/US20070020190A1/en not_active Abandoned
- 2004-02-27 AR ARP040100620A patent/AR043419A1/es not_active Application Discontinuation
- 2004-02-27 DK DK04715295T patent/DK1603565T3/da active
- 2004-02-27 KR KR1020057014683A patent/KR20050104367A/ko not_active Application Discontinuation
- 2004-02-27 JP JP2006501966A patent/JP2006519204A/ja active Pending
- 2004-02-27 RS YUP-2005/0615A patent/RS20050615A/sr unknown
- 2004-02-27 CA CA002517321A patent/CA2517321A1/en not_active Abandoned
- 2004-02-27 PL PL377814A patent/PL377814A1/pl not_active Application Discontinuation
- 2004-02-27 BR BRPI0408047-5A patent/BRPI0408047A/pt not_active IP Right Cessation
- 2004-02-27 EP EP04715295A patent/EP1603565B1/en not_active Expired - Lifetime
- 2004-02-27 NZ NZ541997A patent/NZ541997A/en unknown
- 2004-02-27 WO PCT/EP2004/001960 patent/WO2004075896A1/en active IP Right Grant
- 2004-02-27 SI SI200430815T patent/SI1603565T1/sl unknown
- 2004-02-27 ME MEP-322/08A patent/MEP32208A/xx unknown
- 2004-02-27 CN CNB2004800053713A patent/CN100370986C/zh not_active Expired - Fee Related
- 2004-02-27 AT AT04715295T patent/ATE401887T1/de not_active IP Right Cessation
- 2004-02-27 EP EP07009204A patent/EP1834643A3/en not_active Withdrawn
- 2004-02-27 UA UAA200507796A patent/UA82217C2/uk unknown
- 2004-02-27 EA EA200501108A patent/EA008828B1/ru not_active IP Right Cessation
- 2004-02-27 AU AU2004216472A patent/AU2004216472B2/en not_active Ceased
- 2004-02-27 DE DE602004015260T patent/DE602004015260D1/de not_active Expired - Lifetime
- 2004-02-27 PT PT04715295T patent/PT1603565E/pt unknown
- 2004-02-27 ES ES04715295T patent/ES2309503T3/es not_active Expired - Lifetime
- 2004-02-27 MX MXPA05009007A patent/MXPA05009007A/es active IP Right Grant
- 2004-02-27 ZA ZA200506820A patent/ZA200506820B/en unknown
- 2004-02-27 CN CNA2007101120284A patent/CN101244063A/zh active Pending
- 2004-05-19 SA SA04250122A patent/SA04250122B1/ar unknown
-
2005
- 2005-07-29 TN TNP2005000186A patent/TNSN05186A1/en unknown
- 2005-08-23 HR HR20050726A patent/HRP20050726A2/xx not_active Application Discontinuation
- 2005-08-25 NO NO20053959A patent/NO20053959L/no not_active Application Discontinuation
- 2005-09-06 MA MA28483A patent/MA27630A1/fr unknown
-
2006
- 2006-06-21 HK HK06107053A patent/HK1087009A1/xx not_active IP Right Cessation
-
2008
- 2008-09-19 CY CY20081101023T patent/CY1108360T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053959L (no) | Medikament omfattende hoy-aktiv langtidsvarende beta-2-aqonist i kombinasjon med andre aktive bestanddeler | |
SG169233A1 (en) | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation | |
EA200500902A1 (ru) | Порошковые лекарственные средства, содержащие соль тиотропия и ксинафоат салметерола | |
ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
HUP0402075A2 (hu) | Készítmények nátha kezelésére | |
HUP0401614A2 (hu) | PDE4 inhibitort és antikolinerg hatóanyagot tartalmazó gyógyszerkészítmények és alkalmazásuk | |
EA200501105A1 (ru) | Фармацевтическая композиция | |
HUP0402304A2 (hu) | Deutériummal helyettesített dihidrofuranonszármazékok és azokat tartalmazó gyógyszerkészítmények | |
CA2519679A1 (en) | Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases | |
TNSN05131A1 (en) | New synergistic combination comprising roflumilast and formoterol | |
HUP0400222A2 (hu) | PDE-4 inhibitort és H1 receptor antagonistát tartalmazó kombináció és ennek alkalmazása tüdőbetegségek kezelésére alkalmas gyógyszerkészítmény előállítására | |
SG149876A1 (en) | Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same | |
JP4377564B2 (ja) | 内服用組成物 | |
NO20053023L (no) | Synergistisk kombinasjon omfattende roflumilas og (R,R)-formoterol | |
US20230058134A1 (en) | Aldose reductase inhibitors for the treatment of acute respiratory distress syndrome, acute lung inflammation/injury, cardiac injury and anti-viral therapy | |
EA200500864A1 (ru) | Новый, содержащий тиотропий порошковый препарат для ингаляции | |
HUP0402062A2 (hu) | Alkanoil-L-karnitin alkalmazása merevedési zavar kezelésére és ezt tartalmazó gyógyszerkészítmények | |
DE60308497D1 (de) | Pulverzubereitungen zur inhalation | |
Eccles | Over the counter medicines for colds | |
AU672022B2 (en) | Antiviral combinations | |
BR112023002778A2 (pt) | Ácido (1r,3s)-3-((5-ciano-4-feniltiazol-2-il) carbamoil) ciclopentano-1-carboxílico e derivados do mesmo para uso no tratamento de doenças das vias aéreas | |
TH77905B (th) | ยาชนิดใหม่ซึ่งประกอบรวมด้วย (เบตา)2 -อะโกนิสต์ที่มีการออกฤทธิ์นาน และมีศักยภาพสูงในการใช้ร่วมกับส่วนประกอบออกฤทธิ์อื่นๆ | |
TH77905A (th) | ยาชนิดใหม่ซึ่งประกอบรวมด้วย เบตา2 -อะโกนิสต์ที่มีการออกฤทธิ์นาน และมีศักยภาพสูงในการใช้ร่วมกับส่วนประกอบออกฤทธิ์อื่นๆ | |
JP2001089375A (ja) | 感冒用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |